Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_assertion type Assertion NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_head.
- NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_assertion description "[Overall, the MTHFR Ala222Val polymorphism was not associated with the development of bladder cancer in all genetic models (Ala/Ala vs. Val/Val--OR = 0.961, 95 % CI = 0.763-1.209; Ala/Ala vs. Ala/Val--OR = 0.918, 95 % CI = 0.795-1.060--Ala/Val vs. Val/Val--OR = 1.022, 95 % CI = 0.852-1.227; dominant model--OR = 0.998, 95 % CI = 0.869-1.145; recessive model--OR = 0.921, 95 % CI = 0.794-1.069; Ala allele vs. Val allele--OR = 0.957, 95 % CI = 0.857-1.067).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_provenance.
- NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_assertion evidence source_evidence_literature NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_provenance.
- NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_assertion SIO_000772 23649653 NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_provenance.
- NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_assertion wasDerivedFrom befree-20140225 NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_provenance.
- NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_assertion wasGeneratedBy ECO_0000203 NP238799.RAUMsDnNd6S8bs1Qn9dHWixtc82MAV8108oX7IxwiJGh4130_provenance.